DALLAS, September 4, 2012 ReportsnReports.com adds new a market research report "Partnership Models and Emerging Destinations for R&D Outsourcing" to its store. As outsourcing penetration has increased, pharma companies increasingly compete on how efficiently they interact with CROs. Strategic partnerships arose, in part, as a way to reduce the burden of oversight and costs of contracting. The report reviews how leading players are using strategic outsourcing to conduct drug development.
Features and benefits
- The report reviews how leading players are using strategic outsourcing to conduct drug development.
- The scope includes companies providing preclinical and clinical outsourced development services.